S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda

CNA Financial (CNA) Stock Forecast & Price Target

$44.44
+1.10 (+2.54%)
(As of 04/19/2024 ET)

CNA Financial Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Reduce
Based on 2 Analyst Ratings

Analysts' Consensus Price Target

$46.50
4.64% Upside
High Forecast$50.00
Average Forecast$46.50
Low Forecast$43.00
TypeCurrent Forecast
4/22/23 to 4/21/24
1 Month Ago
3/23/23 to 3/22/24
3 Months Ago
1/22/23 to 1/22/24
1 Year Ago
4/22/22 to 4/22/23
Consensus Rating
Reduce
Reduce
Hold
N/A
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
N/A
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
N/A
Hold
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
N/A
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
N/A
Consensus Price Target$46.50$45.50$41.00N/A
Predicted Upside4.64% Upside-1.76% Downside4.38% UpsideN/A
Get CNA Financial Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CNA and its competitors with MarketBeat's FREE daily newsletter.

CNA Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CNA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CNA Financial Stock vs. The Competition

TypeCNA FinancialFinance CompaniesS&P 500
Consensus Rating Score
1.50
2.44
2.49
Consensus RatingReduceHoldHold
Predicted Upside4.64% Upside74.92% Upside11.96% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/10/2024Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$48.00 ➝ $50.00+13.10%
2/6/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform$39.00 ➝ $43.00-7.37%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:52 PM ET.

CNA Price Target - Frequently Asked Questions

What is CNA Financial's consensus rating and price target?

According to the issued ratings of 2 analysts in the last year, the consensus rating for CNA Financial stock is Reduce based on the current 1 sell rating and 1 hold rating for CNA. The average twelve-month price prediction for CNA Financial is $46.50 with a high price target of $50.00 and a low price target of $43.00. Learn more on CNA's analyst rating history.

Do Wall Street analysts like CNA Financial more than its competitors?

Analysts like CNA Financial less than other Finance companies. The consensus rating for CNA Financial is Reduce while the average consensus rating for finance companies is Hold. Learn more on how CNA compares to other companies.

Is CNA Financial being downgraded by Wall Street analysts?

Over the previous 90 days, CNA Financial's stock had 1 downgrade by analysts.

Does CNA Financial's stock price have much upside?

According to analysts, CNA Financial's stock has a predicted upside of 2.62% based on their 12-month stock forecasts.

What analysts cover CNA Financial?

CNA Financial has been rated by Bank of America, and Keefe, Bruyette & Woods in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:CNA) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners